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Sequence-Specific RNA Binding by a Nova KH Domain:
Implications for Paraneoplastic Disease
and the Fragile X Syndrome
Mass spectrometry combined with limited proteolysis
documented that the three KH motifs of Nova-1 are
proteolytically stable domains connected to one another
by flexible segments of polypeptide chain (Lewis et al.,
1999). Further biophysical characterization of KH do-
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All five of these compact, globular KH domains are com-
posed of a three-stranded, antiparallel b sheet backed
by two or three a helices. There is considerable medicalSummary
interest in the RNA binding properties of the KH domains
of FMR1 and the Nova proteins, because they haveThe structure of a Nova protein K homology (KH) do-
been implicated, respectively, in the fragile X mentalmain recognizing single-stranded RNA has been de-
retardation syndrome and in paraneoplastic opsoclo-termined at 2.4 AÊ resolution. Mammalian Nova anti-
nus-myoclonus ataxia (POMA).gens (1 and 2) constitute an important family of
Fragile X syndrome is an X-linked dominant trait withregulators of RNA metabolism in neurons, first identi-
incomplete penetrance that affects z1 per 1250 malesfied using sera from cancer patients with the autoim-
and z1 per 2000 females, making it the most commonmune disorder paraneoplastic opsoclonus-myoclonus
form of inherited mental retardation (Nussbaum andataxia (POMA). The structure of the third KH domain
Ledbetter, 1995). In most well characterized patients,(KH3) of Nova-2 bound to a stem loop RNA resembles
the syndrome is associated with reduced quantities ofa molecular vise, with 59-Ura-Cyt-Ade-Cyt-39 pinioned
fragile X mental retardation protein (FMR1), which con-between an invariant Gly-X-X-Gly motif and the vari-
tains two KH domains (Siomi et al., 1993b). FMR1 lossable loop. Tetranucleotide recognition is supported
of function is typically caused by transcriptional silenc-by an aliphatic a helix/b sheet RNA-binding platform,
ing of the FMR1 gene due to CGG trinucleotide repeatwhich mimics 59-Ura-Gua-39 by making Watson-Crick-
expansion in the 59-untranslated region (Oberle et al.,
like hydrogen bonds with 59-Cyt-Ade-39. Sequence
1991; Fu et al., 1991; Pieretti et al., 1991; Verkerk et
conservation suggests that fragile X mental retarda-
al., 1991), or by significant derangement of the coding
tion results from perturbation of RNA binding by the segments (Gedeon et al., 1992; Lugenbeel et al., 1995).
FMR1 protein. One particularly severe presentation of fragile X mental
retardation is associated with a single base pair muta-
Introduction tion in the FMR1 gene, leading to an Ile!Asn substitu-
tion of a highly conserved residue within KH2 (De Boulle
Protein±RNA interactions are central to a host of impor- et al., 1993).
tant cellular processes, including protein biosynthesis, POMA is a neurodegenerative syndrome, one of sev-
pre-mRNA processing, RNA localization, and mRNA sta- eral paraneoplastic disorders that arise when systemic
bilization and degradation (Nagai, 1996). Several con- malignant tumors express proteins normally seques-
served protein sequence motifs implicated in RNA bind- tered in the central nervous system (Darnell, 1996). The
ing have been identified over the past decade (Burd and immune system considers these paraneoplastic anti-
Dreyfuss, 1994), one of the most common being the K gens to be nonself, and the predictable immune re-
homology (KH) motif, the subject of this paper. Originally sponse results in neuronal degeneration. In some cases,
identified as a conserved region represented three times actual suppression of tumor growth has been observed
in the hnRNP K protein (Siomi et al., 1993a), KH motifs in patients with paraneoplastic disorders (Darnell and
span about 70 residues with a characteristic pattern of DeAngelis, 1993), making them useful model systems for
hydrophobic residues, an invariant Gly-X-X-Gly seg- studying antitumor immunity (Albert et al., 1998; Darnell,
ment, and a variable loop. Since their initial detection, 1999). POMA arises primarily in patients with breast/
a superfamily of more than 100 KH proteins has been gynecologic tumors that express Nova antigens (Figure
identified in eukaryotes, eubacteria, and archaea (Figure 1) (Luque et al., 1991; Buckanovich et al., 1993; Graus
1; reviewed in Burd and Dreyfuss, 1994; Lewis et al., et al., 1993; Yang et al., 1998), and is associated with
1999). Most KH proteins possess more than one copy cerebellar (Luque et al., 1991) and brain stem (Hormigo
et al., 1994) degeneration.of the KH motif, with some RNA-binding proteins (e.g.,
Considerable effort has been devoted to trying to un-vigilin) containing as many as 15. Nova-1 and Nova-2
derstand the physiologic roles of the Nova proteins andboth contain three KH motifs.
other paraneoplastic disease antigens, because autoan-
tibody disruption of protein function may contribute to§ To whom correspondence should be addressed (e-mail: burley@
neuronal degeneration (Buckanovich et al., 1996; Okanorockvax.rockefeller.edu).
et al., 1999). Initial RNA binding studies using ribohomo-k Present address: Department of Biology, Brookhaven National
Laboratory, Upton, New York 11973. polymers documented that the KH3 domains of Nova-1
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Figure 1. KH Domain Sequence Alignments
Secondary structural elements were assigned on the basis of the X-ray structure. Color coding scheme: yellow, invariant Gly-X-X-Gly motif;
red, variable loop; magenta, aliphatic a/b platform. Functional classifications: A, aliphatic stacking interaction; S, side chain±base hydrogen
bond, including water-mediated contacts; M, protein backbone±base hydrogen bond; *, van der Waals contact. Sequence alignments of
human Nova-1 and Nova-2 KH3, KH1, and KH2, human FMR1 KH1 and KH2 (excluding exon 11), C. elegans GLD-1 KH domain, Drosophila
Bicaudal C KH2, E. coli PNP KH domain, and Methanococcus jannaschii NusA KH domain. KH domain point mutants discussed in the text
are shown in reverse, with the mutant amino acids listed below. Numbers within variable loop segments denote length of the loop.
and Nova-2 are essentially indistinguishable from their number of physiologically relevant RNA targets of the
Nova proteins have been proposed (Buckanovich andfull-length counterparts (Buckanovich et al., 1996). In
vitro RNA selection experiments (SELEX) (Tuerk and Darnell, 1997; Jensen et al., 2000b).
Homozygous Nova-1 knockout mice appear to un-Gold, 1990; Ellington and Szostak, 1992) with full-length
and truncated Nova proteins subsequently demon- dergo normal gestation and development. Shortly after
birth, however, the pups become incapacitated by pro-strated a marked preference for the tetranucleotide
59-Ura-Cyt-Ade-Y-39, where Y denotes pyrimidine (Buck- gressive motor system failure that is correlated with
apoptosis of motor neurons in the brainstem and spinalanovich and Darnell, 1997; Yang et al., 1998; Jensen et
al., 2000a). The stem loop crystallization RNA (Figure 2) cord, both of which are sites of Nova-1 expression.
Death of the homozygous null mice typically occurswas identified during the course of exhaustive SELEX
experiments (Jensen et al., 2000a) with truncated Nova-1 within the first two weeks of life, whereas the heterozy-
gotes appear unaffected (Jensen et al., 2000b). Theseand Nova-2 proteins (KH3 domain plus additional C-ter-
minal residues; Figure 1). During the past few years, a remarkable phenotypic findings occur in the context
Figure 2. Stem Loop RNA Structures
Schematic drawings of the stem loop crystallization RNAs in complexes 1 and 2. Nucleotides making direct protein contacts are denoted
with *. Color coding denotes nucleotides making extensive protein contacts (Ade-11 through Cyt-15; magenta, pink, gold, green, and blue)
and the remaining nucleotides (gray).
KH Domain±RNA Cocrystal Structure
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Table 1. Crystallographic Statistics
Reflections, Completeness (%) Rsym (%),
Data Set Resolution (AÊ ) Measured/Unique Overall/Outer shell Overall/Outer Shell
l1 (0.9194 AÊ ) 20.0±2.60 124,023/62,349 96.8/82.4 5.4/20.8
l2 (0.9188 AÊ ) 20.0±2.60 123,214/63,064 97.3/86.8 5.2/19.3
l3 (0.8856 AÊ ) 20.0±2.60 126,070/63,853 98.3/94.9 5.6/23.9
Overall MAD figure of merit 5 0.215
Refinement Data 20.0±2.40 143,241/67,678 98.0/93.7 8.1/21.1
Refinement Statistics R factor 5 0.208, Free R factor 5 0.291
Rms deviations bond lengths, 0.008 AÊ bond angles, 1.48 thermal parameters, 3.0 AÊ 2
Rsym 5 SjI 2 ,I.j/SI, where I 5 observed intensity, ,I. 5 average intensity obtained from multiple observations of symmetry related reflections.
Rms bond lengths and rms bond angles are the respective root-mean-square deviations from ideal values. Rms thermal parameters is the
root-mean-square deviation between the B values of covalently bonded atomic pairs. Free R factor was calculated with 10% of the data
omitted from the structure refinement.
of neuron-specific splicing defects in the glycine and excellent stereochemistry (Experimental Procedures,
Table 1).GABA-A receptor pre-mRNAs (Jensen et al., 2000b). The
repeated sequence 59-(Ura-Cyt-Ade-Ura-Y)3-39 found
within the intron immediately upstream of alternatively
Structural Overviewspliced exon 3A of the glycine receptor a2 pre-mRNA
The crystal structure of the Nova-2 KH3±RNA complexwas shown to be a bona fide Nova-binding site (Bucka-
is illustrated schematically in Figure 3. The RNA-boundnovich and Darnell, 1997; Jensen et al., 2000b). In vitro
form of Nova-2 KH3 contains three a helices and threesplicing studies with transcripts of a glycine receptor
b strands arranged in order S1-H1-H2-S2-S3-H3. Be-
a2 mini gene containing the Nova-binding site and exon
tween a helices H1 and H2 there is a Gly-Lys-Gly-Gly3A recapitulated the in vivo observations of (Jensen et
310-helical portion, which corresponds to the invariantal., 2000b), proving that sequence-specific RNA binding
Gly-X-X-Gly motif (yellow) present in virtually all KH do-by a Nova protein is both necessary and sufficient for
mains. b strands S2 and S3 are connected by a 10-regulation of neuron-specific alternative splicing of the
residue segment (Lys-43 through Arg-52), referred to asglycine receptor a2 pre-mRNA.
the variable loop (red). Together, the invariant Gly-X-X-In this paper, we report the X-ray structure of a trun-
Gly motif and the variable loop flank an aliphatic a helix/bcated form of Nova-2 bound to a stem loop RNA con-
strand (a/b) platform that supports RNA recognition,taining the 59-Ura-Cyt-Ade-Y-39 core recognition se-
giving the appearance of a molecular vise gripping sin-quence of the glycine receptor a2 pre-mRNA. Our work
gle-stranded nucleic acid. The only significant structuralprovides the three-dimensional structure of a KH do-
difference between free (Lewis et al., 1999) and RNA-main interacting with a high-affinity RNA ligand, demon-
bound forms of Nova-2 KH3 (root-mean-square devia-strating a novel mechanism by which this RNA-binding
tion [rmsd] between common a-carbons 5 0.8 AÊ ) reflectsmotif recognizes single-stranded nucleic acid. The con-
the presence of a C-terminal addition (residues 478±served hydrophobic residue implicated in the develop-
492), which extends a helix H3. The crystallization RNAment of fragile X mental retardation makes an aliphatic
assumes the predicted hairpin configuration (shownstacking interaction with the Ade of 59-Ura-Cyt-Ade-
schematically in Figure 2), with electron density visibleY-39, suggesting that the FMR1 protein deficiency phe-
for all 20 nucleotides in both complexes comprising thenotype is caused by impairment of RNA binding by KH2
asymmetric unit. The stem of the hairpin adopts a stan-of FMR1. The structure also provides insights into the
dard A-form double-helical conformation, with four Wat-nucleic acid binding properties of other KH-containing
son-Crick base pairs (Gua-1:Cyt-20, Ade-2:Ura-19, Gua-proteins.
3:Cyt-18, Gua-4:Cyt-17) and a single hydrogen bond
between Ade-5 and Cyt-16 (N1±O2 5 2.4 AÊ ).
Our structure reveals an unusual single-stranded RNAResults and Discussion
recognition surface, which is neither strictly b sheet nor
a-helical as previously suggested by conservation pat-Crystallization and Structure Determination
The SELEX RNA (Figure 2) plus human Nova-2 KH3 (resi- terns among Nova proteins and the limited structural
database of protein±RNA complexes (Lewis et al., 1999).dues 406±492; Figure 1) yielded high-quality crystals,
containing two crystallographically independent copies Instead, the extended target RNA (Ade-11, Ura-12, Cyt-
13, Ade-14, Cyt-15) lies upon a hydrophobic a/b plat-of a 1:1 protein±RNA complex (denoted 1 and 2) in the
asymmetric unit (Experimental Procedures). Experimen- form (formed by a helices H1 and H2 and the edge of
b strand S2), where it is gripped by the invariant Gly-tal phases were obtained using multiwavelength anoma-
lous dispersion (Hendrickson, 1991), with 5-bromo-ura- X-X-Gly motif and the variable loop, both of which are
often disordered in structures of free KH domains (re-cil substituted for Ura-19. A complete structural model
for both copies of the protein±RNA complex was built viewed in Lewis et al., 1999). It is remarkable that the
platform is exclusively composed of aliphatic sidewith the aid of noncrystallographic averaging. The cur-
rent refinement model has a working R factor of 20.8% chains, some of which also make van der Waals contacts
with conserved residues in the hydrophobic core of theand a free R value of 29.1% at 2.4 AÊ resolution, with
Cell
326
KH domain. Stacking interactions between RNA bases
and aromatic side chains typically seen in protein±RNA
complexes do not contribute to molecular recognition
in this KH domain±RNA complex. Our Nova-2 KH3 co-
crystal structure closely resembles that of Nova-1 KH3
bound to the same stem loop RNA, and a detailed com-
parison will be published elsewhere (H. A. L. et al., un-
published data).
Noncrystallographic Symmetry
The two protein±RNA complexes comprising the crystal-
lographic asymmetric unit (labeled 1 and 2 in Figure 4)
are related to one another by a simple 2-fold rotation.
With the exception of four nucleotides that adopt an
unusual tetraloop conformation in complex 2 but not in
complex 1 (Figure 2), the two halves of the asymmetric
unit are very similar, effectively ruling out substantial
contributions from lattice packing artifacts. a-carbon
rmsd is 0.4 AÊ for protein, and C19 rmsd is 1.2 AÊ for
the crystallization RNA with the tetraloop nucleotides
excluded. The structural similarity of the two RNA±
protein complexes is even more striking if we limit our
analysis to protein a-carbons and C19 atoms of the
59-Ura-Cyt-Ade-Y-39 core recognition sequence (rmsd 5
0.4 AÊ ). A complete analysis of the RNA tetraloop found
in complex 2 will be published elsewhere (H. A. L. et al.,
unpublished data).
The two complexes in the asymmetric unit pack
against each other using interactions between the H3
a helices, which are antiparallel with a crossing angle
of about 508. The two stem loop RNAs lie on opposite
sides of the noncrystallographic dimer, and extend away
from the 2-fold axis. There are no intercomplex protein±
RNA contacts. Formation of the asymmetric unit buries
1172 AÊ 2 of solvent-accessible surface area, which ex-
ceeds the value of 600 AÊ 2, the upper limit for adventitious
crystal-packing contacts (Janin, 1995). Although it is
unclear whether this dimeric organization is of physio-
logic significance, our previous crystallographic work
on the Nova proteins suggests that the dimer depicted
in Figure 4 is stable. Our structures of the free forms of
Nova-1 and Nova-2 KH3 revealed identical tetrameric
arrangements with 22 symmetry (Lewis et al., 1999). One
of the two dimer interfaces stabilizing this KH domain
tetramer is essentially identical to the binary interactions
depicted in Figure 4 (compare Figure 4A with Figure 6
of Lewis et al., 1999).
Recognition of 59-Ura-Cyt-Ade-Y-39 Core Recognition
Sequence of the Glycine Receptor a2 Pre-mRNA
Overview
Nova-2 KH3 binds to the crystallization RNA using a
combination of van der Waals contacts, hydrogen bonds,
2) with a gray ribbon denoting the phosphoribose backbone. a heli-
ces are labeled H1, H2, and H3, and b strands are labeled S1, S2,
and S3. The N and C termini of the protein, and the 59 and 39 ends
of the RNA are labeled. All illustrations and contact distances are
derived from complex 2.
(A) View toward the b sheet face.
(B) View toward the a-helical face.
Figure 3. Structure of the Nova-2 KH3±RNA Complex (C) View down the axis of a helix H3, showing the jaws of the
RIBBONS (Carson, 1991) stereodrawings showing color-coded pro- molecular vise.
tein (invariant Gly-X-X-Gly motif, yellow; variable loop, red). Crystalli- (D) View toward the aliphatic a/b RNA-binding platform, showing
zation RNA is included as a color-coded atomic stick figure (Figure the tetranucleotide gripped by the molecular vise.
KH Domain±RNA Cocrystal Structure
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element. Gly-24 and Gly-25 interact with both Cyt-13
and Ade-14. The variable loop makes two RNA contacts
in complex 1, with Cyt-7 and Cyt-16. In complex 2, the
variable loop interacts with Cyt-6, Cyt-7, Ura-8, Ade-9,
Cyt-13, and Cyt-16. Despite their differences in terms
of RNA contacts, the variable loops in complexes 1 and
2 are very similar (a-carbon rmsd 5 0.6 AÊ ). Not surpris-
ingly, we observed a similar variable loop conformation
in our crystallographic study (Lewis et al., 1999) of the
free form of Nova-2 KH3 (a-carbon rmsd's 5 0.8 AÊ ).
Other residues important for interactions with Ura-12,
Cyt-13, and Ade-14 include Glu-14, Val-17, Gly-18, Ala-
19, Leu-21, Leu-28, Val-29, Ile-39, Ile-41, Ser-42, and
Arg-54. Cyt-15 makes a single contact with Gln-40. In
complex 1, the 29 hydroxyl groups of Ura-8, Ade-11,
Ura-12, Cyt-13, and Cyt-15 participate in hydrogen
bonds with the protein or some other portion of the RNA,
making it unlikely that Nova KH3 will bind tightly to a DNA
oligonucleotide of the same sequence. In complexes
1 and 2, Ade-11 interacts with both N- (Asn-15) and
C-terminal (Arg-83) residues (Figure 5B). This latter con-
tact explains why additional C-terminal residues beyond
the confines of both Nova-1 KH3 and Nova-2 KH3 are
required for high-affinity RNA binding (Jensen et al.,
2000a).
Previously published studies of KH domain mutagene-
sis are entirely consistent with our Nova-2 KH3±RNA
cocrystal structure (depicted schematically in Figure 1).
Figure 4. Noncrystallographic Symmetry
Various mutations have been examined in the C. elegans
(A) Protein/RNA RIBBONS representation of the dimeric assembly
GLD-1 single KH domain protein (Jones and Schedl,comprising the asymmetric unit, viewed perpendicular to the non-
1995). Gly-227!Asp and Gly-227!Ser loss-of-functioncrystallographic 2-fold axis. The KH domains have been colored as
mutations of the first glycine of the invariant Gly-X-X-in Figure 6 of Lewis et al., 1999, and the RNA ribbons are color
coded as in Figures 2 and 3. Gly motif almost certainly interfere with RNA binding via
(B) Viewed along the noncrystallographic 2-fold axis. steric interference and/or electrostatic repulsion by an
improperly positioned negative charge in the vicinity of
the nucleic acid backbone. Similar results were obtained
and stacking interactions (Figure 5). Although their crys-
with the KH domain of E. coli polynucleotide phosphory-
tal lattice environments are not the same, the two crys-
lase or PNP (Garcia-Mena et al., 1999). Two other muta-
tallographically independent protein±RNA complexes
tions in GLD-1, Gly-248!Arg and Gly-250!Arg, map
in the asymmetric unit make essentially identical pro- to the variable loop and cause masculinization of the
tein±ligand interactions, burying portions of both the germline. This portion of Nova-2 KH3 interacts with RNA,
protein and RNA surfaces (total solvent-accessible area thereby suggesting that the C. elegans phenotype re-
buried 5 1900±1967 AÊ 2 for each complex). Of the 20 sults from a change in the RNA binding properties of
nucleotides in the stem loop RNA, eight interact with GLD-1. Drosophila WHO protein also demonstrates a
protein in complex 1 and 11 in complex 2 (denoted * in loss-of-function mutation in the variable loop, Arg-
Figure 2). The majority of these contacts involve the 185!Cys, analogous to those seen in GLD-1 (Baeh-
Ade-11 through Cyt-15 segment (59-Ade-Ura-Cyt-Ade- recke, 1997). In Drosophila Bicaudal C (Mahone et al.,
Cyt-39), which is gripped by the jaws of the KH domain 1995), a Gly-295!Arg loss-of-function mutation of the
molecular vise. Ura-12, Cyt-13, and Ade-14 sit directly conserved Gly at the C terminus of S3 probably disrupts
atop the a/b aliphatic platform, pinioned between the the fold of the KH domain. Similar reasoning explains
invariant Gly-X-X-Gly motif and the variable loop. All of the deleterious effect of the Ala-294!Thr mutation in
the amino acids involved in direct RNA contacts are GLD-1, which maps to the hydrophobic face of a
absolutely conserved between Nova-1 and Nova-2, helix H3.
which explains why these two closely related KH3 do- How Does the KH3 Domain Recognize
mains (92% sequence identity) demonstrate essentially 59-Ura-Cyt-Ade-Y-39?
identical nucleic acid binding specificity (Jensen et al., Ura-12 occurs in the usual anti conformation (Figure
2000a). 5C), permitting van der Waals interactions with Gly-18
The invariant Gly-X-X-Gly motif (Gly-22, Lys-23, Gly- (closest approach 5 3.3 AÊ ) and Ala-19 (closest
24, Gly-25 in the KH3 domains of both Nova-1 and approach 5 3.4 AÊ ). Two water molecules form bridges
Nova-2) serves as one jaw of the vise, and appears to be between the base and Lys-23 (N±H2O 5 2.8 AÊ , H2O±O2 5
critical for interactions with the nucleic acid backbone 3.4 AÊ ) and Arg-75 (NH2±H2O 5 3.4 AÊ , H2O±N3 5 3.5 AÊ ),
(Figure 5). Gly-22 and Lys-23 make numerous contacts providing for indirect detection of Ura at position one
with the sugar-phosphates and bases of Ura-12 and of the tetranucleotide consensus sequence. This envi-
ronment appears to be compatible with Cyt, which wasCyt-13, the first two members of the tetranucleotide
Cell
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Figure 5. 59-Ura-Cyt-Ade-Cyt-39 Binding by
Nova-2 KH3
RIBBONS drawings showing the RNA-bind-
ing surface sandwiched between the invari-
ant Gly-X-X-Gly motif (yellow) and the vari-
able loop (red). The portion of the stem loop
crystallization RNA making extensive protein
contacts has been included as a color-coded
stick figure (Figure 2) with the aliphatic resi-
dues (gray) comprising the hydrophobic a/b
RNA binding platform. (A) shows the entire
complex. (B), (C), and (D) show the environ-
ments of Ade-11 Ura-12, and Cyt-13, respec-
tively. (E) shows the environments of Ade-
14 and Cyt-15. The side chain of Leu-28 is
denoted with *. (F) corresponds to the views
used in (D) and (E), with the overlying RNA
removed, and shows the aliphatic platform
with the jaws of the molecular vise.
tolerated in the context of an exhaustive mutational anal- the hydrophobic amino acids (Leu-21, Leu-28 and Ile-
41) forming the aliphatic a/b platform of the molecularysis performed with the crystallization RNA (Jensen et
al., 2000a). The larger purine bases would, we believe, vise (Figure 5E). On the opposite face, an intrastrand
stacking interaction with Cyt-15 (distance of closest ap-be precluded by steric clashes with the protein.
Unlike Ura-12, Cyt-13 was shown to be absolutely proach 5 3.1 AÊ ) completes the binding site for Ade-14
(Figure 5). This environment is entirely specific for Ade,required for high-affinity RNA binding (Jensen et al.,
2000a). At this position in the tetranucleotide recognition and is reminiscent of the ATP-binding sites found in the
active centers of protein kinases (reviewed in Taylorsequence, two protein side chains form a hydrogen
bond network that allows the protein to act as a molecu- and Radzio-Andzelm, 1994). Like Nova-2 KH3, these
enzymes employ polypeptide backbone mimicry of Uralar mimic of Gua (Figure 5D). Arg-54 donates two hydro-
gen bonds to acceptors on Cyt-13 (NH2±O2 5 3.4 AÊ , creating Watson-Crick-like hydrogen bonds with an Ade
base sitting atop an aliphatic platform.NH1±N3 5 3.1 AÊ ), and Glu-14 serves as a hydrogen bond
acceptor (OE1±N4 5 2.7 AÊ ). Arg-54 and Glu-14 make The final member of the tetranucleotide core recogni-
tion sequence was always found to be a pyrimidine (50%an intramolecular interaction (NH1±OE2 5 2.9 AÊ ) that
stabilizes their approach to Cyt-13. The location of Cyt- Cyt, 50% Ura) in our Nova SELEX experiments (Jensen
et al., 2000a), a finding which is reflected in the environ-13 is further restricted by an intrastrand hydrogen bond
with the phosphate group of Ura-12 (N4±O1P 5 3.1 AÊ ), ment of Cyt-15 (Figure 5E). Intrastrand stacking interac-
tions are provided by Ade-14 (see above for distanceand van der Waals contacts with Val-17 and Leu-21 from
a helix H1 (distances of closest approach 5 3.2 AÊ and of closest approach) and Cyt-16 (distance of closest
approach 5 3.3 AÊ ). The observed base contact with3.5 AÊ , respectively). This complicated network of inter-
actions is only compatible with Cyt at position two of Gln-40 is compatible with either Cyt or Ura (NE2±O2 5
3.3 AÊ ). Steric considerations rule out the larger purinethe 59-Ura-Cyt-Ade-Y-39 core recognition sequence.
Ade-14 is also recognized by a combination of Wat- bases at this position in the tetranucleotide.
son-Crick-like hydrogen bonds with the protein and an
intrastrand contact (Figure 5). The backbone of Ile-41
on the edge of b strand S2 mimics Ura (N±N1 5 3.2 AÊ , Comparison with Other Protein±RNA
Cocrystal StructuresO±N6 5 2.7 AÊ ), and O29 of Cyt-13 donates a hydrogen
bond that specifies purine (O29±N7 5 3.5 AÊ ). Ade-14 Previously published crystal structures of RNA-binding
proteins interacting with single-stranded nucleic acidsengages in a number of van der Waals interactions with
KH Domain±RNA Cocrystal Structure
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include work on RNA recognition motifs or RRMs (Ou- which may be further compromised by changes in the
identity of the preceding nucleotide. Similar argumentsbridge et al., 1994; Price et al., 1998; Deo et al., 1999;
Ding et al., 1999; Handa et al., 1999), rho transcription suggest that the preferences for Ura and pyrimidine at
the 59 and 39 ends of the tetranucleotide, respectively,termination factor (Bogden et al., 1999), vaccinia virus
methyltransferase VP39 (Hodel et al., 1998), bacterio- may be altered. Although experimental verification of
these predictions is not available for all four Nova KHphage MS2 coat protein (Valegard et al., 1994), trp RNA-
binding attenuation protein (Antson et al., 1999), and domains, we know that truncations of both Nova-1 (KH1
plus KH2) and Nova-2 (KH2) do not bind avidly to 59-Ura-several tRNA/protein complexes (reviewed in Cusack,
1997). The most common protein structural element em- Cyt-Ade-Y-39 (Buckanovich and Darnell, 1997; Jensen et
al., 2000a).ployed in RNA recognition is the b sheet as exemplified
by the RRM motif, which fueled expectations that RNA What then is the function of the KH1 and KH2 domains
of Nova-1 and Nova-2? In the absence of definitivebinding might occur on the b sheet surface of the KH
domain. SELEX results, we cannot even be sure that they are
capable of high-affinity RNA binding. Further analysisIn our cocrystal structure, single-stranded RNA binds
to an a/b aliphatic platform, created by juxtaposition of of sequence similarities among Nova KH domains does,
however, suggest that they should bind RNA in a similartwo a helices and the edge of a b sheet, which is flanked
by the invariant Gly-X-X-Gly motif and the variable loop. fashion. All six KH domains of the human Nova antigens
share the same Gly-X-X-Gly motif (Gly-Lys-Gly-Gly) anda/b binding surfaces have been observed in only three
other protein±RNA complexes, including VP-39, glutam- possess highly similar variable loops (Figure 1). More-
over, homology modeling results suggest that they allinyl-tRNA synthetase-tRNAglu (Rould et al., 1991), and
threonyl-tRNA synthetase-tRNAthr (Saknaranarayanan et share the same aliphatic a/b platform between the jaws
of the molecular vise (data not shown). Additional SELEXal., 1999). The Nova-2 KH3±RNA complex does not re-
semble any one of these structures, making KH domains experiments have yielded presumptive evidence that
Nova-1 KH1 and Nova-2 KH2 recognize different RNAa distinct class of sequence-specific RNA-binding pro-
teins. sequences (K. B. J., K. M., and R. B. D., unpublished
observations).
Our cocrystal structure demonstrates that individualImplications for RNA Binding by Full-Length
Nova KH3 domains are not capable of recognizing moreNova Proteins
than about four or five nucleotides in a row. Gene-spe-Three lines of evidence suggest that 59-Ura-Cyt-Ade-
cific regulation of pre-mRNA splicing must, therefore,Y-39 recognition by the Nova proteins is exclusively me-
require interplay with additional specificity determinantsdiated by KH3. First, all available POMA antisera are
(i.e., other RNA sequences and/or RNA-bound proteins).directed against Nova-1 and Nova-2 KH3, and incuba-
The structure of the asymmetric unit depicted in Figuretion of Nova proteins with these antibody mixtures inter-
4 and the presence of three copies of the target tetranu-feres with RNA binding (Buckanovich et al., 1996; Yang
cleotide upstream of exon 3A of the glycine receptor a2et al., 1998). Second, full-length Nova proteins and their
pre-mRNA [59-(Ura-Cyt-Ade-Ura-Y)3-39] are consistentKH3 domains display identical RNA binding specificity
with two copies of Nova-1 KH3 binding to the first andfor 59-UraCyt-Ade-Y-39, albeit with somewhat reduced
third tetranucleotides simultaneously. The distance be-affinities for the KH3 domains (Buckanovich and Darnell,
tween the 39 end of the tetranucleotide in complex 11997; Jensen et al., 2000a). Third, the sequence align-
and the 59 end of the same sequence in complex 2 isments depicted in Figure 1 argue against 59-Ura-Cyt-
about 37 AÊ , which is compatible with six nucleotidesAde-Y-39 recognition by the remaining KH domains of
connecting the two recognition sequences. We suggestNova-1 and Nova-2.
that the physiologic target of Nova-1 in the glycine re-Although Nova-1 KH1 and KH2, and Nova-2 KH1 and
ceptor a2 pre-mRNA consists of two tetranucleotideKH2 are very similar in amino acid sequence to both
sites separated by a six-nucleotide spacer (59-Ura-Cyt-Nova-1 KH3 and Nova-2 KH3 (Nova-1: KH1 versus KH3,
Ade-Ura-Y-Ura-Cyt-Ade-Ura-Y-Ura-Cyt-Ade-Ura-Y-39,39% identity; KH2 versus KH3, 38%; Nova-2: KH1 versus
italics denote tetranucleotides interacting with a NovaKH3, 36%, KH2 versus KH3, 35%; Figure 1), our cocrys-
KH3 dimer). Additional, albeit indirect, support for atal structure of Nova-2 KH3 makes it very unlikely that
Nova dimer interacting with two half-sites comes fromthese four additional Nova KH domains bind tightly to the
work with Nova-1, which documented that simultaneous59-Ura-Cyt-Ade-Cyt-39 tetranucleotide. Potentially impor-
mutation of Ade!Ura in the first and third tetranucleo-tant differences occur at positions 14 (Ser or Asn instead
tide core recognition sequences abolishes RNA bindingof Glu), 17 (Ala instead of Val), 19 (Leu or Ser instead of
(Buckanovich and Darnell, 1997). Our dimer model forAla), 21 (Ile instead of Leu), 28 (Ile and Val instead of
Nova binding is reminiscent of the behavior of someLeu), 40 (Lys instead of Gln), and 41 (Leu instead of Ile).
dimeric transcription factors, such as E2 or the steroid/The chemically significant variation at position 14 (Ser
nuclear receptors (reviewed in Patikoglou and Burley,or Asn instead of Glu) almost certainly interferes with
1997). This analogy with eukaryotic transcription alsorecognition of the invariant Cyt, because Glu-14 is criti-
underscores the possibility of RNA recognition by Nova-cal for molecular mimicry of Gua by the KH domain.
1/Nova-2 heterodimers, which were detected in vitro byConservative substitutions at positions 21, 28, and 41
Yang et al. (1998). Finally, it is remarkable that the RNAare unlikely to affect the ability of the KH domain to
binding properties of the Nova proteins resemble thoseact as a molecular mimic of Ura, because polypeptide
of hnRNP K and hnRNP E1 (Figure 1), which recognizebackbone atoms are used to make hydrogen bonds with
tetranucleotide DICE repeats in the 39 untranslated re-N1 and N6 of Ade. Alterations in the aliphatic platform
could, however, affect binding of the invariant Ade, gion of 15-lipoxygenase mRNA (Ostareck et al., 1997).
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Implications for Fragile X Syndrome pre-mRNA and regulate splicing in neurons. Using se-
Our Nova-2 KH3±RNA cocrystal structure also provides quence comparisons with other KH domains, we have
some insight into how a single point mutation in KH2 of been able to propose a general model for interactions
FMR1 (Ile!Asn, corresponding to Leu-28 illustrated in of these proteins with RNA. This exercise proved to be
Figure 5) results in fragile X syndrome mental retarda- particularly pertinent to the fragile X syndrome, because
tion. Analogous substitutions in various KH domains it provides a structural framework with which to try to
expressed in E. coli yielded denatured proteins, as understand how FMR1 loss-of-function mutations cause
judged by CD spectroscopy (reviewed in Lewis et al., the most common form of inherited mental retardation.
1999). Although these observations suggested that Our work also provides a starting point for further crys-
FMR1 could be inactivated by a nonconservative substi- tallographic, biochemical, and genetic studies of KH
tution destabilizing the structure of KH2, they did not domains and their roles in pre-mRNA splicing, RNA lo-
prove that the Ile!Asn point mutation interferes with calization, translational control, and mRNA stabilization/
folding of the KH2 domain in vivo. Feng et al. (1997) degradation.
used human cell lines derived from a normal volunteer
and the fragile X patient possessing the Ile!Asn muta- Experimental Procedures
tion to demonstrate that mutant FMR1 protein is ex-
Protein and RNA Preparation and Crystallizationpressed at normal levels in vivo and remains associated
Nova-2 KH3 (residues 406±492) was expressed in E. coli and purifiedwith mRNAs. Further analysis of the mutant protein did,
as described in Lewis et al., 1999. The measured molecular masshowever, reveal a significant functional defect. Unlike
for this truncated from of Nova-2 was 9752 6 4 (predicted 5 9749),
wild-type FMR1, which associates with elongating poly- confirming that the protein was neither truncated nor posttransla-
ribosomes via large mRNP particles, the mutant protein tionally modified during expression or purification. Circular dichro-
associates with abnormal, smaller RNPs. ism spectroscopy was used to document that the protein was prop-
erly folded, and RNA binding activity measurements were carriedThe altered Ile in FMR1 KH2 corresponds to Leu-28
out as described in Jensen et al., 2000a. Crystallization RNA wasin our cocrystal structure (Figure 5E, marked with *). The
purchased from Dharmacon Research, deprotected according toside chain of this aliphatic residue is directed away from
the manufacturer's instructions, and purified by anion-exchange
the hydrophobic core of the KH domain, with the CD2 chromatography followed by desalting.
methyl group making van der Waals interactions with Nova-2 KH3±RNA cocrystals were obtained by sitting drop vapor
Ade-14. Sequence similarities between FMR1 KH2 and diffusion against 25% PEG MME 5000, 150 mM ammonium sulfate,
100 mM MES, pH 6.5, at 208C with a protein concentration of 155the two Nova KH3 domains suggest that they use a
mM and a 1:1.25 protein:RNA ratio. After streak seeding, the ortho-common aliphatic a/b RNA±binding platform flanked by
rhombic crystals grow in space group P212121 (a 5 47.8 AÊ , b 5the invariant Gly-X-X-Gly motif and the variable loop
51.2 AÊ , c 5 128.6 AÊ ), with two protein±RNA complexes/asymmetric(Figure 1). Of the four residues comprising this hy-
unit, and diffract to at least 2.4 AÊ resolution. For MAD phasing,
drophobic surface, one is identical (Val-17) and the other 5-bromo-uracil was substituted for Ura-19 in the crystallization oli-
three are chemically similar to those found in Nova-1 gonucleotide.
and Nova-2 KH3 (Leu-21 and Leu-28 are both Ile, and
Data Collection, Structure Determination, and RefinementIle-41 is Val). Model building results obtained using our
Diffraction data at three X-ray wavelengths in the vicinity of theNova-2 KH3 cocrystal structure suggest that introduc-
bromine K absorption edge (Table 1) were collected from a singletion of an isostructural asparagine instead of Leu-28
frozen crystal using Beamline X25 of the National Synchrotron Lightwould leave the hydrophobic interior of the KH domain
Source (NSLS) at Brookhaven National Laboratory. The bromine
unchanged, because they both possess CB and CG atoms were located using SOLVE (Terwilliger and Berendzen, 1997),
atoms (Figure 5E). Assuming that the mutant Asn residue and an interpretable electron density map was obtained using
adopts the same conformation as Leu-28, OD1 and ND2 MLPHARE and DM (Dodson et al., 1997) with the aid of 2-fold non-
crystallographic averaging. After model building, the structure wasof the polar side chain would replace CD1 and CD2 of
refined to convergence at 2.4 AÊ resolution with CNS (Brunger et al.,Leu and change the electrostatic properties of the a/b
1998), using diffraction data from CHESS Beamline A1 (Cornell HighRNA±binding platform making it significantly less hy-
Energy Synchrotron Source, Cornell University). The final refinementdrophobic. We believe that such a substitution will
model includes Nova-2 KH3 residues 3±90 (complex 1) and 4±87
affect interactions between FMR1 KH2 and a single- (complex 2), both copies of all 20 nucleotides of the crystallization
stranded RNA target pinioned between the invariant Gly- RNA, and 138 water molecules (see Table 1 for refinement statistics).
X-X-Gly motif and the variable loop. The development PROCHECK (Laskowski et al., 1993) revealed no unfavorable (`,c)
combinations in the KH3±RNA complex, with main chain and sideof fragile X mental retardation in the patient bearing the
chain structural parameters consistently better than average (overallIle!Asn mutation could, therefore, result from perturba-
G value 5 0.2). Atomic coordinates are available from the Proteintion of sequence-specific RNA binding, making it imper-
Data Bank (PDB Code 1EC6).ative that we fully understand the RNA binding proper-
ties of FMR1.
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